Literature DB >> 17404808

Bile acid transporters: structure, function, regulation and pathophysiological implications.

Waddah A Alrefai1, Ravinder K Gill.   

Abstract

Specific transporters expressed in the liver and the intestine, play a critical role in driving the enterohepatic circulation of bile acids. By preserving a circulating pool of bile acids, an important factor influencing bile flow, these transporters are involved in maintaining bile acid and cholesterol homeostasis. Enterohepatic circulation of bile acids is fundamentally composed of two major processes: secretion from the liver and absorption from the intestine. In the hepatocytes, the vectorial transport of bile acids from blood to bile is ensured by Na+ taurocholate co-transporting peptide (NTCP) and organic anion transport polypeptides (OATPs). After binding to a cytosolic bile acid binding protein, bile acids are secreted into the canaliculus via ATP-dependent bile salt excretory pump (BSEP) and multi drug resistant proteins (MRPs). Bile acids are then delivered to the intestinal lumen through bile ducts where they emulsify dietary lipids and cholesterol to facilitate their absorption. Intestinal epithelial cells reabsorb the majority of the secreted bile acids through the apical sodium dependent bile acid transporter (ASBT) and sodium independent organic anion transporting peptide (OATPs). Cytosolic ileal bile acid binding protein (IBABP) mediates the transcellular movement of bile acids to the basolateral membrane across which they exit the cells via organic solute transporters (OST). An essential role of bile acid transporters is evident from the pathology associated with their genetic disruption or dysregulation of their function. Malfunctioning of hepatic and intestinal bile acid transporters is implicated in the pathophysiology of cholestatic liver disease and the depletion of circulating pool of bile acids, respectively. Extensive efforts have been recently made to enhance our understanding of the structure, function and regulation of the bile acid transporters and exploring new potential therapeutics to treat bile acid or cholesterol related diseases. This review will highlight current knowledge about structure, function and molecular characterization of bile acid transporters and discuss the implications of their defects in various hepatic and intestinal disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404808     DOI: 10.1007/s11095-007-9289-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  208 in total

1.  Regulation of expression of human intestinal bile acid-binding protein in Caco-2 cells.

Authors:  T Kanda; L Foucand; Y Nakamura; I Niot; P Besnard; M Fujita; Y Sakai; K Hatakeyama; T Ono; H Fujii
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

2.  Sodium-dependent taurocholate uptake by isolated rat hepatocytes occurs through an electrogenic mechanism.

Authors:  C E Bear; J S Davison; E A Shaffer
Journal:  Biochim Biophys Acta       Date:  1987-10-02

3.  Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.

Authors:  Mikko Niemi; Katja A Arnold; Janne T Backman; Marja K Pasanen; Ute Gödtel-Armbrust; Leszek Wojnowski; Ulrich M Zanger; Pertti J Neuvonen; Michel Eichelbaum; Kari T Kivistö; Thomas Lang
Journal:  Pharmacogenet Genomics       Date:  2006-11       Impact factor: 2.089

4.  Sterol regulatory element-binding protein-1c is responsible for cholesterol regulation of ileal bile acid-binding protein gene in vivo. Possible involvement of liver-X-receptor.

Authors:  Isabelle Zaghini; Jean-Francois Landrier; Jacques Grober; Stephane Krief; Stacey A Jones; Marie-Claude Monnot; Isabelle Lefrere; Michael A Watson; Jon L Collins; Hiroshi Fujii; Philippe Besnard
Journal:  J Biol Chem       Date:  2001-10-29       Impact factor: 5.157

5.  Regional intestinal absorption and biliary excretion of fluvastatin in the rat: possible involvement of mrp2.

Authors:  Anders Lindahl; Asa Sjöberg; Ulf Bredberg; Helena Toreson; Anna-Lena Ungell; Hans Lennernäs
Journal:  Mol Pharm       Date:  2004 Sep-Oct       Impact factor: 4.939

6.  Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer.

Authors:  J Grober; I Zaghini; H Fujii; S A Jones; S A Kliewer; T M Willson; T Ono; P Besnard
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

7.  Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver.

Authors:  C J Soroka; J M Lee; F Azzaroli; J L Boyer
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

8.  Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis.

Authors:  Anne Figge; Frank Lammert; Beverly Paigen; Anne Henkel; Siegfried Matern; Ron Korstanje; Benjamin L Shneider; Frank Chen; Erik Stoltenberg; Kathryn Spatz; Farzana Hoda; David E Cohen; Richard M Green
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

9.  Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences.

Authors:  C Thomas; J-F Landrier; D Gaillard; J Grober; M-C Monnot; A Athias; P Besnard
Journal:  Gut       Date:  2006-02-16       Impact factor: 23.059

10.  Characterization of the mechanisms involved in the gender differences in hepatic taurocholate uptake.

Authors:  F R Simon; J Fortune; M Iwahashi; S Bowman; A Wolkoff; E Sutherland
Journal:  Am J Physiol       Date:  1999-02
View more
  129 in total

1.  Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBT.

Authors:  Fadi Annaba; Zaheer Sarwar; Ravinder K Gill; Amit Ghosh; Seema Saksena; Alip Borthakur; Gail A Hecht; Pradeep K Dudeja; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 2.  Molecular mechanisms underlying chemical liver injury.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Expert Rev Mol Med       Date:  2012-02-03       Impact factor: 5.600

Review 3.  Structural insights into the transport of small molecules across membranes.

Authors:  Nicholas Noinaj; Susan K Buchanan
Journal:  Curr Opin Struct Biol       Date:  2014-03-28       Impact factor: 6.809

Review 4.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

5.  Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acids.

Authors:  Pablo M González; Carlos F Lagos; Weslyn C Ward; James E Polli
Journal:  Mol Pharm       Date:  2013-12-26       Impact factor: 4.939

6.  Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katerina Dvorak; George S Watts; Lois Ramsey; Hana Holubec; Claire M Payne; Carol Bernstein; Gareth J Jenkins; Richard E Sampliner; Anil Prasad; Harinder S Garewal; Harris Bernstein
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

7.  Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation.

Authors:  Eun Sun Jang; Jung-Hwan Yoon; Sung-Hee Lee; Soo-Mi Lee; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Hyo-Suk Lee; Chung Yong Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-27       Impact factor: 4.553

Review 8.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

Review 9.  Bile acid transporters in health and disease.

Authors:  A Kosters; S J Karpen
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

10.  GATA4 is essential for jejunal function in mice.

Authors:  Michele A Battle; Benjamin J Bondow; Moriah A Iverson; Scott J Adams; Ronald J Jandacek; Patrick Tso; Stephen A Duncan
Journal:  Gastroenterology       Date:  2008-08-03       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.